يعرض 1 - 10 نتائج من 134 نتيجة بحث عن '"de Castro Carpeño, Javier"', وقت الاستعلام: 1.42s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Isla D Hospital Universitario Lozano Blesa, IIS Aragón, Saragossa, Spain. Felip E Vall d’Hebron Hospital Universitari, Barcelona, Spain. Garrido P Hospital Universitario Ramón y Cajal, Madrid, Spain. Insa A Hospital Clínico Universitario de Valencia, Valencia, Spain. Majem M Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Remon J CIOCC HM Nou Delfos, Barcelona, Spain. Trigo JM HC Marbella-Hospital International, Málaga, Spain. de Castro J Hospital Universitario La Paz-IDIPAZ, Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Clinical and Translational Oncology;25; https://doi.org/10.1007/s12094-022-02941-5Test; Isla D, Felip E, Garrido, P, Insa A, Majem M, Remon J, et al. A Delphi consensus panel about clinical management of early-stage EGFR-mutated non-small cell lung cancer (NSCLC) in Spain: a Delphi consensus panel study. Clin Transl Oncol. 2023 Jan;25:283–91.; https://hdl.handle.net/11351/9030Test; 000860445100002

  2. 2
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, De Castro J Hospital Universitario La Paz, Madrid, Spain. Insa A Hospital Clínico Universitario de Valencia, Valencia, Spain. Collado-Borrell R, Escudero-Vilaplana V Hospital General Universitario Gregorio Marañon, Madrid, Spain. Martínez A Vall d’Hebron Hospital Universitari, Barcelona, Spain. Fernandez E OSI Bilbao-Basurto, Bilbao, Spain. Sullivan I Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: BMC Pulmonary Medicine;23(1); https://doi.org/10.1186/s12890-023-02356-0Test; De Castro J, Insa A, Collado-Borrell R, Escudero-Vilaplana V, Martínez A, Fernandez E, et al. Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in Spain. BMC Pulm Med. 2023 Feb 21;23(1):69.; https://hdl.handle.net/11351/9133Test

  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: Clinical & Translational Oncology; Vol. 23 Núm. 7 (july 2021), p. 1304-1313; https://ddd.uab.cat/record/271924Test; urn:10.1007/s12094-020-02518-0; urn:oai:ddd.uab.cat:271924; urn:scopus_id:85096206315; urn:articleid:16993055v23n7p1304; urn:pmid:33210237; urn:pmc-uid:8192379; urn:pmcid:PMC8192379; urn:oai:pubmedcentral.nih.gov:8192379

  8. 8
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Borghaei H Fox Chase Cancer Center, Philadelphia, PA. Gettinger S Yale Comprehensive Cancer Center, New Haven, CT. Vokes EE Univeristy of Chicago Medicine and Biologic Sciences Division, Chicago, IL. Chow LQM University of Washington, Seattle Cancer Care Alliance, Seattle, WA. Burgio MA Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. de Castro Carpeno J Hospital De Madrid, Norte Sanchinarro, Madrid, Spain. Felip E Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Journal of Clinical Oncology;39(7); https://doi.org/10.1200/JCO.20.01605Test; Borghaei H, Gettinger S, Vokes EE, Chow LQM, Burgio MA, de Castro Carpeno J, et al. Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer. J Clin Oncol. 2021 Mar 1;39(7):723–33.; https://hdl.handle.net/11351/7634Test; 000635371200005

  9. 9
    دورية أكاديمية

    المصدر: Hurtado , F K , de Braud , F , De Castro Carpeño , J , de Miguel Luken , M J , Wang , D , Scott , J , Lau , Y Y , McCulloch , T & Mau-Sorensen , M 2021 , ' Effect of ceritinib on the pharmacokinetics of coadministered CYP3A and 2C9 substrates : a phase I, multicenter, drug–drug interaction study in patients with ALK + advanced tumors ' , Cancer Chemotherapy and Pharmacology , vol. 87 , no. 4 , pp. 475-486 . https://doi.org/10.1007/s00280-020-04180-3Test

    وصف الملف: application/pdf

  10. 10
    دورية أكاديمية